These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 9822360)

  • 1. Pulmonary Kaposi's sarcoma in AIDS patients treated with combined chemotherapy and recombinant human granulocyte colony-stimulating factor.
    Mastroianni A; Coronado O; Cancellieri C; Manfredi R; Pignatari S; Chiodo F
    J Chemother; 1998 Oct; 10(5):405-10. PubMed ID: 9822360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma.
    Gill PS; Mitsuyasu RT; Montgomery T; Huang J; Cabriales S; Testa M; Espina BM; Levine AM; Miles SA
    Cancer J Sci Am; 1997; 3(5):278-83. PubMed ID: 9327151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adriamycin, bleomycin and vincristine chemotherapy with recombinant granulocyte-macrophage colony-stimulating factor in the treatment of AIDS-related Kaposi's sarcoma.
    Gill PS; Bernstein-Singer M; Espina BM; Rarick M; Magy F; Montgomery T; Berry MS; Levine A
    AIDS; 1992 Dec; 6(12):1477-81. PubMed ID: 1283520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial.
    Gill PS; Rarick M; McCutchan JA; Slater L; Parker B; Muchmore E; Bernstein-Singer M; Akil B; Espina BM; Krailo M
    Am J Med; 1991 Apr; 90(4):427-33. PubMed ID: 1707230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.
    Gill PS; Wernz J; Scadden DT; Cohen P; Mukwaya GM; von Roenn JH; Jacobs M; Kempin S; Silverberg I; Gonzales G; Rarick MU; Myers AM; Shepherd F; Sawka C; Pike MC; Ross ME
    J Clin Oncol; 1996 Aug; 14(8):2353-64. PubMed ID: 8708728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha, zidovudine, and granulocyte-macrophage colony-stimulating factor: a phase I AIDS Clinical Trials Group study in patients with Kaposi's sarcoma associated with AIDS.
    Krown SE; Paredes J; Bundow D; Polsky B; Gold JW; Flomenberg N
    J Clin Oncol; 1992 Aug; 10(8):1344-51. PubMed ID: 1634925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of poor prognosis epidemic Kaposi's sarcoma with doxorubicin, bleomycin, vindesine and recombinant human granulocyte-monocyte colony stimulating factor (rh GM-CSF).
    Bakker PJ; Danner SA; ten Napel CH; Kroon FP; Sprenger HG; van Leusen R; Meenhorst PL; Muusers A; Veenhof CH
    Eur J Cancer; 1995; 31A(2):188-92. PubMed ID: 7536434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I AIDS Clinical Trials Group (075) study of adriamycin, bleomycin and vincristine chemotherapy with zidovudine in the treatment of AIDS-related Kaposi's sarcoma.
    Gill PS; Miles SA; Mitsuyasu RT; Montgomery T; McCarthy S; Espina BM; Feldstein M; Levine AM
    AIDS; 1994 Dec; 8(12):1695-9. PubMed ID: 7534090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.
    Northfelt DW; Dezube BJ; Thommes JA; Miller BJ; Fischl MA; Friedman-Kien A; Kaplan LD; Du Mond C; Mamelok RD; Henry DH
    J Clin Oncol; 1998 Jul; 16(7):2445-51. PubMed ID: 9667262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MOPP/ABV/CAD chemotherapy with and without recombinant human granulocyte-macrophage colony stimulating factor in untreated, unfavorable prognosis Hodgkin's disease.
    Riccardi A; Gobbi P; Danova M; Giordano M; Pieresca C; Bertoloni D; Brugnatelli S; Ascari E
    Haematologica; 1993; 78(1):44-8. PubMed ID: 7684012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy and alpha-interferon in the treatment of Kaposi's sarcoma associated with acquired immune deficiency syndrome.
    Shepherd FA; Evans WK; Garvey B; Read SE; Klein M; Fanning MM; Coates R
    CMAJ; 1988 Oct; 139(7):635-9. PubMed ID: 2458177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I trial to assess the value of recombinant human granulocyte colony stimulating factor (R-MeTHuG-CSF, filgrastim) in accelerating the dose rate of chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma (NHL). The Central Lymphoma Group.
    Smith GM; Child JA; Cullen MH; Bailey NP; Woodruffe CM; Fletcher J; Earl H; Barnard D
    Hematol Oncol; 1996 Dec; 14(4):193-201. PubMed ID: 9267465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
    Stein ME; Lachter J; Spencer D; Bezwoda WR
    Int J Dermatol; 1995 Oct; 34(10):729-32. PubMed ID: 8537166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group.
    Stewart S; Jablonowski H; Goebel FD; Arasteh K; Spittle M; Rios A; Aboulafia D; Galleshaw J; Dezube BJ
    J Clin Oncol; 1998 Feb; 16(2):683-91. PubMed ID: 9469358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with adriamycin, bleomycin, vincristine (ABV) palliative chemotherapy in advanced AIDS-related Kaposi's sarcoma.
    Paparizos VA; Kyriakis KP; Mileounis KA; Pfandl-Polydorou D; Stavrianeas NG; Vareltzidis AG; Stratigos JD
    J Chemother; 1996 Oct; 8(5):403-6. PubMed ID: 8957723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
    Welte K; Reiter A; Mempel K; Pfetsch M; Schwab G; Schrappe M; Riehm H
    Blood; 1996 Apr; 87(8):3143-50. PubMed ID: 8605328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.
    Crawford J; Ozer H; Stoller R; Johnson D; Lyman G; Tabbara I; Kris M; Grous J; Picozzi V; Rausch G
    N Engl J Med; 1991 Jul; 325(3):164-70. PubMed ID: 1711156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immune deficiency syndrome.
    Gelmann EP; Longo D; Lane HC; Fauci AS; Masur H; Wesley M; Preble OT; Jacob J; Steis R
    Am J Med; 1987 Mar; 82(3):456-62. PubMed ID: 2435150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of granulocyte colony-stimulating factor (filgrastim) in maintaining dose intensity during conventional-dose chemotherapy with ABVD in Hodgkin's disease.
    Silvestri F; Fanin R; Velisig M; Barillari G; Virgolini L; Zaja F; Russo D; Baccarani M
    Tumori; 1994 Dec; 80(6):453-8. PubMed ID: 7534963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.